Everything listed here is Research Use Only (RUO). Not for human or animal consumption.
Growth Hormone & Performance · Washington, DC
IGF-1 LR3 is documented by ReVia for cell-biology and growth-factor research labs across Washington, DC and the East Coast region. This long-acting insulin-like growth factor analogue with an extended half-life is studied for cell proliferation and muscle-hypertrophy pathways in laboratory models, with each lot supported by third-party COA testing. Provided for research use only to the District and nearby Arlington and Alexandria.
A long-acting analog of insulin-like growth factor 1 with an arginine substitution at position 3 and a 13-amino acid N-terminal extension. Studies have investigated its enhanced anabolic activity and reduced IGF binding protein affinity.
The Washington, DC capital region's science-forward market gives laboratories ready interest in IGF-1 LR3, an extended-action growth-factor analog studied in vitro. Benches in Arlington, Alexandria, and Bethesda examine its IGF-1 receptor affinity and the proliferation cascades it activates in cultured cells. The Long R3 peptide functions as a preclinical model for growth-factor signaling research, handled entirely within the controlled laboratory setting across the metro.
IGF-1 LR3 is worked with by researchers throughout the Washington metro — including Arlington, Alexandria, Bethesda, Silver Spring — and across East Coast. The capital region's science-forward market. Every ReVia-branded lot carries its own certificate of analysis, and the compound is intended strictly for research use.
Where do researchers in Washington, DC obtain IGF-1 LR3?
IGF-1 LR3 is supplied through i2b Health, ReVia's research partner, to researchers in Washington, DC and surrounding areas including Bethesda and Arlington. All supply is designated research use only.
Does IGF-1 LR3 include third-party COA testing?
Every IGF-1 LR3 batch is independently tested, and a certificate of analysis documenting purity and identity is available. This supports reproducible work in the capital region's research labs.
What is IGF-1 LR3 studied for?
IGF-1 LR3 is researched as a long-acting analogue for cell proliferation and muscle-hypertrophy signaling in laboratory models. It is intended only for in-vitro research, not for human or animal use.
For research use only. Not for human or veterinary use. The information on this page is provided for educational and research purposes and does not constitute medical advice.